|
|
Exercising the Metabolome
Education and Metabolism & Energy Tracks
|
Saturday, April
5 — 3:15-5:15 PM
San Diego Convention Center — Ballroom 20A
|
|
Chaired: |
David G. Parkes, Amylin Pharmaceuticals
Alastair V. Ferguson, Queen’s Univ. |
Bioinformatic and proteomic analysis of the human genome
has resulted in the discovery of several novel, biologically active
proteins. Many of these proteins are produced in and released from
adipocytes, gastrointestinal tract and central nervous system sites
known to be important in appetite regulation and metabolic function.
Once identified, the broad spectrum of biologic actions must be
characterized, and determined to be either physiologically relevant or
potentially therapeutically important. Just as the task of discovery
requires a wide variety of bioinformatic and proteomic approaches, while
the characterization of the biologic effect of novel, secreted proteins
requires multiple experimental approaches to gain an understanding of
the role(s) played by these factors in integrative, systems biology.
This symposium will focus on several recently characterized proteins
known to have physiologically relevant actions on metabolic function and
detail strategies for the characterization of the biologic action of
those proteins. Speakers will focus on proteins involved in appetite,
metabolism and glucose homeostasis.
|
3:15 PM |
Discovering the actions of amylin.
Andrew A. Young, Amylin Pharmaceuticals
|
|
3:45 PM |
Integration of satiety signals by
brainstem POMC and catecholamine neurons.
Suzanne Appleyard, Washington State University
|
|
4:15 PM |
Peripheral and central effects of ghrelin: role of AMPkinase.
Blerina Kola, Barts and the London, Queen Mary School of
Medicine and Dentistry
|
|
4:45 PM |
Cellular basis of nutrient and hormone signaling in the
hypothalamus.
Denise Belsham, Univ. of Toronto
|
|
|